What are the signs of Heparin-Induced Thrombocytopenia (HIT)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Signs of Heparin-Induced Thrombocytopenia (HIT)

The key signs of Heparin-Induced Thrombocytopenia (HIT) include thrombocytopenia (typically moderate with platelet counts 30-70 G/L) occurring 5-10 days after heparin initiation, paradoxical thrombosis despite low platelets, and a 4T score ≥4 points. 1

Clinical Presentation

Platelet Count Patterns

  • Typical thrombocytopenia pattern:
    • Moderate thrombocytopenia (usually 30-70 G/L, rarely <20 G/L) 1
    • 50% or greater drop from baseline platelet count (even if absolute count remains >150 × 10⁹/L) 1
    • Platelet count nadir typically 50-60 × 10⁹/L 2

Timing of Onset

  • Three distinct patterns:
    1. Typical onset: 5-10 days after starting heparin therapy 1
    2. Rapid onset: Within 24 hours in patients with recent heparin exposure (within past 30-100 days) 1, 3
    3. Delayed onset: Up to 3 weeks after heparin discontinuation 1

Thrombotic Complications

  • Venous thrombosis: Most common (17-55% of untreated patients) 1
    • Deep vein thrombosis (DVT)
    • Pulmonary embolism (PE)
  • Arterial thrombosis: Less common (3-10%) 1
    • Limb artery thrombosis
    • Thrombotic stroke
    • Myocardial infarction
  • Important note: In up to 25% of patients, thrombosis precedes thrombocytopenia 1

Special Consideration After Cardiac Surgery

  • Two patterns should raise suspicion for HIT: 1
    • Platelet count fall beginning ≥4 days post-surgery
    • Thrombocytopenia persisting ≥4 days after surgery

Less Common Manifestations

  • Skin manifestations: Necrotizing skin lesions at heparin injection sites 1, 4
  • Venous limb gangrene: In 5-10% of HIT patients with DVT treated with vitamin K antagonists 1
  • Adrenal hemorrhagic necrosis: Due to adrenal vein thrombosis 1
  • Acute systemic reactions: Within 30 minutes of IV heparin bolus 1
    • Fever/chills
    • Tachycardia
    • Hypertension
    • Dyspnea
    • Cardiopulmonary arrest
  • Disseminated intravascular coagulation: Severe enough to deplete fibrinogen 1

Diagnostic Approach: The 4T Score

The 4T score is the most validated clinical prediction rule for HIT, assessing four key parameters: 1, 5

  1. Thrombocytopenia (0-2 points)

    • 2 points: >50% platelet count fall AND nadir ≥20 × 10⁹/L
    • 1 point: 30-50% platelet count fall OR nadir 10-19 × 10⁹/L
    • 0 points: <30% platelet count fall OR nadir <10 × 10⁹/L
  2. Timing of platelet count fall (0-2 points)

    • 2 points: Clear onset between days 5-10 OR ≤1 day (with recent heparin exposure)
    • 1 point: Consistent with days 5-10 fall but unclear OR onset after day 10 OR ≤1 day (with heparin exposure 30-100 days ago)
    • 0 points: Platelet count fall ≤4 days without recent exposure
  3. Thrombosis or other sequelae (0-2 points)

    • 2 points: Confirmed new thrombosis OR skin necrosis OR acute systemic reaction after IV heparin bolus
    • 1 point: Progressive or recurrent thrombosis OR non-necrotizing skin lesions OR suspected thrombosis
    • 0 points: None
  4. Other causes of thrombocytopenia (0-2 points)

    • 2 points: No other apparent cause
    • 1 point: Possible other cause present
    • 0 points: Definite other cause present

Interpretation:

  • Low probability (0-3 points): 0-3% chance of HIT
  • Intermediate probability (4-5 points): ~14% chance of HIT
  • High probability (6-8 points): ~64% chance of HIT

Laboratory Confirmation

  • HIT is a clinicopathologic syndrome requiring both clinical features and laboratory confirmation 1
  • Laboratory tests detect antibodies against the heparin-PF4 complex 6, 7
  • Important note: Many patients develop anti-PF4/heparin antibodies without clinical HIT (especially after cardiac surgery) 1

Key Pitfalls to Avoid

  1. Failing to consider HIT in patients with thrombosis despite thrombocytopenia
  2. Mistaking HIT for other causes of thrombocytopenia (sepsis, drugs, DIC) 1
  3. Continuing heparin when HIT is suspected - immediate discontinuation is required 4, 8
  4. Starting warfarin before platelet recovery - can precipitate venous limb gangrene 2
  5. Missing delayed-onset HIT occurring after heparin discontinuation 1
  6. Overlooking HIT in patients with platelet counts >150 × 10⁹/L who have had a significant percentage drop 1

Clinical Implications

  • Mortality rate: 5-10% of HIT patients die, usually from thrombotic complications 1
  • Paradoxical nature: Despite thrombocytopenia, bleeding is rare; thrombosis risk is high 1, 6
  • Alternative anticoagulation is mandatory when HIT is suspected or confirmed 7, 2

Remember that early recognition of HIT signs is critical, as the thrombosis rate is approximately 5% per day in untreated patients 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Heparin-induced thrombocytopenia: when a low platelet count is a mandate for anticoagulation.

Hematology. American Society of Hematology. Education Program, 2009

Guideline

Diagnosis and Management of Bicytopenia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Heparin induced thrombocytopenia.

The Journal of the Association of Physicians of India, 2008

Research

Heparin-induced thrombocytopenia: pathophysiology and new treatment options.

Pathophysiology of haemostasis and thrombosis, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.